CPHI Barcelona has strong showing as bio/pharma industry moves confidently into 2024.
BioPharm International®, Pharmaceutical Technology®, and Pharmaceutical Technology Europe® see a confident bio/pharma industry ready for the new year and looking to merge technology platforms for emerging opportunities.
CPHI Barcelona ran from Oct. 24–26, 2023.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.